Inventor
ZALE STEPHEN E
US50 patents
⚠️ This page may combine multiple inventors who share the name “ZALE STEPHEN E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BIND THERAPEUTICS INC
16 patentsUS8637083B2Jan 28, 2014
Stable formulations for lyophilizing therapeutic particles
BIND THERAPEUTICS INC82 citations99
US8617608B2Dec 31, 2013
Drug loaded polymeric nanoparticles and methods of making and using same
BIND THERAPEUTICS INC119 citations99
US8613954B2Dec 24, 2013
Drug loaded polymeric nanoparticles and methods of making and using same
BIND THERAPEUTICS INC114 citations99
US8603499B2Dec 10, 2013
Cancer cell targeting using nanoparticles
BIND THERAPEUTICS INC112 citations99
US8603500B2Dec 10, 2013
Cancer cell targeting using nanoparticles
BIND THERAPEUTICS INC111 citations99
US8603535B2Dec 10, 2013
Stable formulations for lyophilizing therapeutic particles
BIND THERAPEUTICS INC85 citations99
US8603534B2Dec 10, 2013
Drug loaded polymeric nanoparticles and methods of making and using same
BIND THERAPEUTICS INC97 citations99
US8603501B2Dec 10, 2013
Cancer cell targeting using nanoparticles
BIND THERAPEUTICS INC113 citations99
US9295727B2Mar 29, 2016
Cancer cell targeting using nanoparticles
BIND THERAPEUTICS INC33 citations98
US8623417B1Jan 7, 2014
Therapeutic polymeric nanoparticles with mTOR inhibitors and methods of making and using same
BIND THERAPEUTICS INC29 citations92
US8912212B2Dec 16, 2014
Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
BIND THERAPEUTICS INC7 citations84
US9198874B2Dec 1, 2015
Long circulating nanoparticles for sustained release of therapeutic agents
BIND THERAPEUTICS INC3 citations63
US8956657B2Feb 17, 2015
Stable formulations for lyophilizing therapeutic particles
BIND THERAPEUTICS INC2 citations63
US9498443B2Nov 22, 2016
Stable formulations for lyophilizing therapeutic particles
BIND THERAPEUTICS INC0 citations52
US9351933B2May 31, 2016
Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same
BIND THERAPEUTICS INC1 citations52
US8905997B2Dec 9, 2014
Therapeutic particles suitable for parenteral administration and methods of making and using same
BIND THERAPEUTICS INC1 citations50
ZALE STEPHEN E
9 patentsUS8613951B2Dec 24, 2013
Therapeutic polymeric nanoparticles with mTor inhibitors and methods of making and using same
ZALE STEPHEN E147 citations99
US8318211B2Nov 27, 2012
Therapeutic polymeric nanoparticles comprising vinca alkaloids and methods of making and using same
ZALE STEPHEN E149 citations99
US8318208B1Nov 27, 2012
Drug loaded polymeric nanoparticles and methods of making and using same
ZALE STEPHEN E145 citations99
US8273363B2Sep 25, 2012
Cancer cell targeting using nanoparticles
ZALE STEPHEN E82 citations99
US8246968B2Aug 21, 2012
Cancer cell targeting using nanoparticles
ZALE STEPHEN E193 citations99
US8236330B2Aug 7, 2012
Cancer cell targeting using nanoparticles
ZALE STEPHEN E146 citations99
US8206747B2Jun 26, 2012
Drug loaded polymeric nanoparticles and methods of making and using same
ZALE STEPHEN E182 citations99
US9393310B2Jul 19, 2016
Drug loaded polymeric nanoparticles and methods of making and using same
ZALE STEPHEN E4 citations84
US9308179B2Apr 12, 2016
Long circulating nanoparticles for sustained release of therapeutic agents
ZALE STEPHEN E1 citations51
ALKERMES INC
7 patentsUS6495164B1Dec 17, 2002
Preparation of injectable suspensions having improved injectability
ALKERMES INC246 citations98
US5916597AJun 29, 1999
Composition and method using solid-phase particles for sustained in vivo release of a biologically active agent
ALKERMES INC601 citations98
US6667061B2Dec 23, 2003
Preparation of injectable suspensions having improved injectability
ALKERMES INC89 citations97
US5716644AFeb 10, 1998
Composition for sustained release of non-aggregated erythropoietin
ALKERMES INC244 citations97
US5674534AOct 7, 1997
Composition for sustained release of non-aggregated erythropoietin
ALKERMES INC238 citations97
US7371406B2May 13, 2008
Preparation of injectable suspensions having improved injectability
ALKERMES INC32 citations92
US7799345B2Sep 21, 2010
Preparation of injectable suspensions having improved injectability
ALKERMES INC6 citations73
PFIZER
6 patentsUS9579386B2Feb 28, 2017
Drug loaded polymeric nanoparticles and methods of making and using same
PFIZER2 citations84
US10071056B2Sep 11, 2018
Cancer cell targeting using nanoparticles
PFIZER2 citations73
US9872848B2Jan 23, 2018
Stable formulations for lyophilizing therapeutic particles
PFIZER2 citations73
US9579284B2Feb 28, 2017
Therapeutic polymeric nanoparticles with mTOR inhibitors and methods of making and using same
PFIZER4 citations73
US10137088B2Nov 27, 2018
Therapeutic nanoparticles having EGFR ligands and methods of making and using same
PFIZER2 citations63
US9835572B2Dec 5, 2017
Therapeutic polymeric nanoparticle compositions with high glass transition temperature or high molecular weight copolymers
PFIZER0 citations51
BIND BIOSCIENCES INC
3 patentsUS8357401B2Jan 22, 2013
Stable formulations for lyophilizing therapeutic particles
BIND BIOSCIENCES INC30 citations96
US8734846B2May 27, 2014
Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles
BIND BIOSCIENCES INC135 citations94
US8916203B2Dec 23, 2014
Stable formulations for lyophilizing therapeutic particles
BIND BIOSCIENCES INC1 citations62